iRadimed(IRMD) - 2025 Q1 - Quarterly Results

Financial Performance - The company reported record revenue of $19.5 million for Q1 2025, an increase of 11$17.6 million in Q1 2024[3] - GAAP diluted EPS for Q1 2025 was $0.37, reflecting a 16$0.32 in Q1 2024, while non-GAAP diluted EPS was $0.42, up 17$0.36[7] - Revenue for Q1 2025 increased to $19,510,637, up 10.3$17,598,119 in Q1 2024[33] - Non-GAAP net income for Q1 2025 was $5.3 million, an increase of 15$4.6 million in Q1 2024[8] - Net income for Q1 2025 rose to $4,687,429, a 13.3$4,136,533 in Q1 2024[33] - Non-GAAP net income for Q1 2025 was $5,341,672, compared to$4,633,159 in Q1 2024, reflecting a 15.3% increase[35] - Basic net income per share increased to $0.37 in Q1 2025 from$0.33 in Q1 2024, while diluted EPS rose to $0.37 from$0.32[33] Future Guidance - The company expects Q2 2025 revenue to be between $19.7 million and$19.9 million, with GAAP diluted EPS guidance of $0.37 to$0.40 and non-GAAP diluted EPS of $0.41 to$0.44[4] - For the full year 2025, the company reaffirms revenue guidance of $78.0 million to$82.0 million, with GAAP diluted EPS of $1.55 to$1.65 and non-GAAP diluted EPS of $1.71 to$1.81[4] Cash Flow and Expenses - Cash flow from operations for Q1 2025 was $4.3 million, a 10$3.9 million in Q1 2024[10] - Free cash flow for Q1 2025 was $374,792, a significant decrease from$3,404,351 in Q1 2024, primarily due to increased capital expenditures[37] - Operating expenses for Q1 2025 totaled $9,411,350, an increase from$8,639,376 in Q1 2024, driven by higher general and administrative and sales and marketing costs[33] Assets and Equity - Total current assets as of March 31, 2025, were $75,136,765, slightly up from$74,706,209 as of December 31, 2024[31] - Total assets increased to $101,729,435 as of March 31, 2025, compared to$98,325,775 as of December 31, 2024[31] - Total stockholders' equity grew to $90,054,430 as of March 31, 2025, up from$86,818,756 as of December 31, 2024[31] Sales and Dividends - Domestic sales accounted for 82% of total revenue in Q1 2025, up from 76% in the same period of 2024[9] - The company declared a regular quarterly cash dividend of $0.17 per share, payable on May 30, 2025[5] Profit Margins - The gross profit margin remained constant at 76.1$14,842,806, representing a gross margin of 76.0%, compared to $13,387,723 and a margin of 76.1$3.0 million in cash for the construction of its new facility in Orlando, Florida, expected to be completed in July 2025[10]